Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Arndt

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer Letters|October 30, 2016
Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K)Stefan Eder, Annette Arndt, Andreas Lamkowski, et al.
Plos One|June 1, 2013
Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infectionJulie Steinestel, Marcus V Cronauer, Johannes Müller, et al.
Oncotarget|July 11, 2019
Detecting predictive androgen receptor modifications in circulating prostate cancer cellsJulie Steinestel, Manuel Luedeke, Annette Arndt, et al.
Journal of Biotechnology|July 13, 2010
RamA and RamB are global transcriptional regulators in Corynebacterium glutamicum and control genes for enzymes of the central metabolismMarc Auchter, Annette Cramer, Andrea Hüser, et al.
Cancers|April 14, 2026
Adenosine Pathway Activation Defines Genetically Linked Immunosuppressive Subtypes in Solid Tumor Brain MetastasesArthur Bauer, Annette Arndt, Luisa Reichenbach, et al.
Oncotarget|June 19, 2014
Potential clinical implications of BRAF mutations in histiocytic proliferationsAnna-Maria Bubolz, Stephanie E Weissinger, Albrecht Stenzinger, et al.
Annals of Hematology|February 24, 2025
The mutational landscape and its longitudinal dynamics in relapsed and refractory classic Hodgkin lymphomaHanno Witte, Axel Künstner, Thomas Hahn, et al.
The Oncologist|July 3, 2024
Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinomaAnnette Arndt, Christian Neumann, Armin Riecke, et al.
Histopathology|September 5, 2025
Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE studyFelix Elsner, Christiane Kümpers, German Ott, et al.
Scientific Data|October 1, 2022
A manually curated compendium of expression profiles for the microbial cell factory Corynebacterium glutamicumAngela Kranz, Tino Polen, Christian Kotulla, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Letters|October 30, 2016
Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K)Stefan Eder, Annette Arndt, Andreas Lamkowski, et al.
Plos One|June 1, 2013
Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infectionJulie Steinestel, Marcus V Cronauer, Johannes Müller, et al.
Oncotarget|July 11, 2019
Detecting predictive androgen receptor modifications in circulating prostate cancer cellsJulie Steinestel, Manuel Luedeke, Annette Arndt, et al.
Journal of Biotechnology|July 13, 2010
RamA and RamB are global transcriptional regulators in Corynebacterium glutamicum and control genes for enzymes of the central metabolismMarc Auchter, Annette Cramer, Andrea Hüser, et al.
Cancers|April 14, 2026
Adenosine Pathway Activation Defines Genetically Linked Immunosuppressive Subtypes in Solid Tumor Brain MetastasesArthur Bauer, Annette Arndt, Luisa Reichenbach, et al.
Oncotarget|June 19, 2014
Potential clinical implications of BRAF mutations in histiocytic proliferationsAnna-Maria Bubolz, Stephanie E Weissinger, Albrecht Stenzinger, et al.
Annals of Hematology|February 24, 2025
The mutational landscape and its longitudinal dynamics in relapsed and refractory classic Hodgkin lymphomaHanno Witte, Axel Künstner, Thomas Hahn, et al.
The Oncologist|July 3, 2024
Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinomaAnnette Arndt, Christian Neumann, Armin Riecke, et al.
Histopathology|September 5, 2025
Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE studyFelix Elsner, Christiane Kümpers, German Ott, et al.
Scientific Data|October 1, 2022
A manually curated compendium of expression profiles for the microbial cell factory Corynebacterium glutamicumAngela Kranz, Tino Polen, Christian Kotulla, et al.
Pageof 3